| Abbreviation | Spelling | Context and Comment |
| SBRT | Sterotactic body radiotherapy | Very precise radiation given in 1–5 treatment sessions |
| MASCC | Multinational Association for Supportive Care in Cancer | Organization which includes experts that provide guidelines for improving side effects of cancer and cancer treatment |
| ESMO | European Society of Clinical Oncology | Organization of cancer professionals to share information and guidelines to develop better ways to treat cancer in Europe and other regions. The academic journal is ESMO Open |
| ASCO | American Society of Clinical Oncology | World’s largest organization of cancer professionals to share information and guidelines to develop better ways to treat cancer. Academic journal is the Journal of Clinical Oncology |
| NCCN | National Comprehensive Cancer Network | An organization devoted to providing guidelines for treatment of specific cancers and issues related to cancer treatment |
| PG-SGA | Patient Generated Subjective Global Assessment | A tool to help identify malnutrition and cachexia in cancer patients at risk for sarcopenia |
| OBD | Optimal biologic dose | Dose of an agent that achieves best effect against a target with acceptable toxicity (for example effect on immune activation) |
| MTD | Maximally tolerated dose | Dose of a drug (e.g., chemotherapy drug) for which an increase dose would have unacceptable toxicity. Once the MTD is determined in a phase I clinical trial, this becomes the recommended phase 2 dose of an anti-cancer agent |
| AUC | Area under the curve | A pharmacokinetic/pharmacodynamic concept that reflects the graph of drug concentration over time. Usually, an inverted U shape because of absorption, distribution, and metabolism, and elimination of an agent |
| VEGF | Vascular endothelial growth factor | A protein involved in generation of new blood vessels to heal wounds or injury or associated with tumors growing new blood vessels. Some anti-cancer drugs block VEGF |
| NG | Naso-gastric | Usually refers to thin tube that extends from the nose to the stomach to provide liquid nutrition, suspensions of drugs, or fluids without swallowing |
| G-tube | Gastrostomy tube | A tube that goes directly from abdominal skin through the muscles and lining of the abdomen into the stomach. Same use as NG but without the discomfort of a tube in the nose or back of the throat |
| SRS | Stereotactic radiosurgery | Ultraprecise radiation that may require a “halo” device or anesthesia to give the dose to tumor only in the brain or near the spinal cord |
| N/V | Nausea and/or vomiting | The most common side effect of cancer chemotherapy |
| 5HT | 5-hydroxytryptamine (serotonin) | The 5-HT3 receptor is triggered in the brain chemoreceptor trigger zone to cause drug associated N/V. Inhibitors of 5-HT are very useful as anti-emetics to reduce or prevent chemotherapy associated N/V |
| TPN | Total parenteral nutrition | An intravenous solution containing glucose, amino acids, vitamins, and sometimes lipids that is used when patients cannot eat or drink adequate amounts of nutrients |
| TKI | Tyrosine kinase inhibitors | A class of drugs that act to block cancer-associated tyrosine kinase enzyme(s) in cancer cells that facilitate cancer growth |
| WART | Whole abdominal radiotherapy | A radiation technique to provide a moderately high dose of radiation to the entire abdomen with relative sparing of liver and kidneys and treating intestines and intestinal lining to tolerance dose. |
| RT | Radiotherapy | Use of radiation as a treatment modality for cancer |
| BMT | Bone marrow transplant | High-dose chemotherapy followed by infusion of marrow or blood stem cells to allow recovery of blood cell production |
| G-CSF | Granulocyte colony stimulating factor | A subcutaneous injection given after chemotherapy to increase granulocyte (neutrophil) production by the bone marrow to make chemotherapy safer |
| KPS | Karnofsky performance scale | A scale from 0% (dead) to 100% (full activity without limitation) to indicate how active a cancer patient is and whether or not activity (performance) is limited by symptoms of drugs, radiation, or cancer |
| PT/OT | Physical therapy and/or occupational therapy | PT involves improving function, exercise, and strength training. OT involves learning how to do activities of daily living better (e.g., climbing stairs, opening a jar, buttoning a shirt) |
| GNRI | Geriatric Nutrition Risk Index | A composite compilation of risk factors to help with malnutritional assessment in older people |
| MNA | Mini-Nutritional Assessment | A composite compilation of risk factors to help with malnutritional assessment |
| PRO | Patient reported outcome | A self-assessment form (if electronic it is an ePRO) |
| BMI | Body mass index | A calculation involving height and weight that can give a number to indicate thin, normal or obese (e.g., BMI > 30) |